US Stock MarketDetailed Quotes

JNJ Johnson & Johnson

Watchlist
  • 145.540
  • +0.090+0.06%
Close Jun 14 16:00 ET
  • 145.540
  • 0.0000.00%
Post 19:57 ET
350.27BMarket Cap9.64P/E (TTM)

Johnson & Johnson Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Oct 1, 2023
(Q2)Jul 2, 2023
(Q1)Apr 2, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Oct 2, 2022
(Q2)Jul 3, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
-24.20%6.28B
5.58B
Net income from continuing operations
4,886.76%3.26B
95.94%35.15B
15.03%4.05B
483.85%26.03B
6.86%5.14B
-101.32%-68M
-14.07%17.94B
-25.68%3.52B
21.57%4.46B
--4.81B
Operating gains losses
----
-5,452.89%-21.1B
--0
---21.05B
13.33%-39M
95.24%-8M
38.41%-380M
-943.75%-167M
--0
---45M
Depreciation and amortization
-3.46%1.82B
7.40%7.49B
4.01%1.84B
8.55%1.83B
10.89%1.93B
6.27%1.88B
-5.68%6.97B
-3.85%1.77B
-7.11%1.69B
--1.74B
Deferred tax
-1.23%-1.56B
-152.19%-4.19B
-392.36%-2.41B
502.88%560M
43.85%-799M
-66.63%-1.54B
20.01%-1.66B
70.10%825M
92.60%-139M
---1.42B
Other non cash items
----
--483M
----
----
----
----
----
----
----
----
Change In working capital
-114.94%-338M
162.50%2.51B
362.07%3.25B
-1,906.67%-602M
-79,933.33%-2.4B
182.62%2.26B
5.36%-4.01B
20.98%-1.24B
-100.86%-30M
---3M
-Change in receivables
-416.67%-279M
51.63%-624M
-24.58%227M
-22.93%-252M
43.17%-545M
87.35%-54M
46.29%-1.29B
151.54%301M
18.65%-205M
---959M
-Change in inventory
33.59%-348M
47.65%-1.32B
119.08%124M
-13.87%-706M
66.97%-217M
12.67%-524M
-102.48%-2.53B
-828.57%-650M
-72.22%-620M
---657M
-Change in payables and accrued expense
3.46%-2.48B
113.66%2.35B
75.76%1.68B
31.58%1.73B
-8.26%1.51B
8.70%-2.57B
-54.94%1.1B
-57.56%957M
-69.02%1.31B
--1.65B
-Change in other current assets
449.62%3.2B
-606.55%-3.48B
45.46%-2.11B
-121.43%-222M
-109.04%-229M
-191.96%-915M
134.98%687M
4.20%-3.88B
55.32%1.04B
--2.53B
-Change in other current liabilities
-106.75%-427M
382.36%5.59B
64.02%3.33B
26.10%-1.15B
-13.83%-2.92B
5,652.73%6.33B
-86.52%-1.98B
131.36%2.03B
-96.95%-1.55B
---2.57B
Cash from discontinued investing activities
Operating cash flow
12.28%3.66B
7.54%22.79B
46.97%7.86B
19.18%7.49B
-25.07%4.18B
-18.15%3.26B
-9.47%21.19B
-6.66%5.35B
-24.20%6.28B
--5.58B
Investing cash flow
Cash flow from continuing investing activities
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
37.44%-1.7B
-2.64B
Net PPE purchase and sale
6.49%-807M
-13.32%-4.54B
-0.13%-1.59B
-1.58%-967M
-30.24%-1.12B
-42.17%-863M
-9.78%-4.01B
-12.16%-1.59B
-27.44%-952M
---863M
Net intangibles purchase and sale
----
---470M
----
----
----
----
--0
----
----
----
Net business purchase and sale
---1.81B
--0
--0
--0
--0
--0
-29,320.00%-17.65B
-28,450.00%-17.13B
--1M
---271M
Net investment purchase and sale
-91.26%349M
-8.03%8.48B
-80.96%2.68B
1,163.86%4.42B
-52.19%-2.6B
247.03%3.99B
271.21%9.23B
519.32%14.06B
84.42%-415M
---1.71B
Net other investing changes
870.43%1.81B
-4,089.23%-2.59B
-811.33%-1.82B
-170.75%-907M
-125.00%-51M
410.00%186M
-84.41%65M
148.21%256M
-148.41%-335M
--204M
Cash from discontinued investing activities
Investing cash flow
-114.00%-464M
107.10%878M
72.66%-1.2B
249.38%2.54B
-43.08%-3.78B
191.22%3.32B
-42.47%-12.37B
17.97%-4.4B
37.44%-1.7B
---2.64B
Financing cash flow
Cash flow from continuing financing activities
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
-77.84%-3.93B
-2.26B
Net issuance payments of debt
-66.04%4.37B
-136.69%-2.73B
-115.03%-1.1B
-6,336.13%-7.42B
-78,955.56%-7.1B
41,448.39%12.88B
852.73%7.45B
243,200.00%7.29B
-81.80%119M
--9M
Net common stock issuance
58.30%-1.48B
86.53%-813M
83.64%-216M
57.51%-920M
496.71%3.86B
-124.29%-3.54B
-74.62%-6.04B
-32.53%-1.32B
-453.71%-2.17B
---973M
Cash dividends paid
2.48%-2.87B
-0.75%-11.77B
3.01%-2.87B
3.33%-2.87B
-4.07%-3.09B
-5.56%-2.94B
-5.89%-11.68B
-5.84%-2.95B
-6.41%-2.97B
---2.97B
Proceeds from stock option exercised by employees
1,872.73%195M
-17.68%1.09B
-55.69%187M
650.57%653M
-46.89%265M
-103.43%-11M
28.28%1.33B
85.09%422M
-67.17%87M
--499M
Net other financing activities
227.38%321M
-2,564.62%-1.6B
61.80%-665M
-175.50%-758M
-93.79%73M
32.44%-252M
-83.54%65M
-1,481.75%-1.74B
1,692.86%1B
--1.18B
Cash from discontinued financing activities
Financing cash flow
-91.10%546M
-78.39%-15.83B
-373.82%-4.66B
-188.33%-11.32B
-164.97%-5.99B
239.98%6.14B
36.85%-8.87B
149.48%1.7B
-77.84%-3.93B
---2.26B
Net cash flow
Beginning cash position
54.73%21.86B
-2.48%14.13B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
3.59%14.49B
-35.50%11.36B
-23.37%10.98B
--10.46B
Current changes in cash
-70.58%3.74B
16,441.67%7.84B
-24.39%2.01B
-295.59%-1.29B
-920.12%-5.59B
414.60%12.71B
-107.06%-48M
186.59%2.65B
-80.44%658M
--681M
Effect of exchange rate changes
-546.43%-125M
64.10%-112M
5.04%125M
41.26%-168M
39.75%-97M
75.00%28M
-75.28%-312M
324.53%119M
-210.87%-286M
---161M
End cash Position
-5.18%25.47B
54.73%21.86B
54.73%21.86B
73.74%19.73B
92.87%21.18B
156.76%26.87B
-2.48%14.13B
-2.48%14.13B
-35.50%11.36B
--10.98B
Free cash flow
19.05%2.85B
3.45%17.78B
54.24%5.8B
22.32%6.52B
-35.18%3.06B
-29.00%2.39B
-13.02%17.19B
-12.83%3.76B
-29.31%5.33B
--4.72B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Oct 1, 2023(Q2)Jul 2, 2023(Q1)Apr 2, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Oct 2, 2022(Q2)Jul 3, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B-24.20%6.28B5.58B
Net income from continuing operations 4,886.76%3.26B95.94%35.15B15.03%4.05B483.85%26.03B6.86%5.14B-101.32%-68M-14.07%17.94B-25.68%3.52B21.57%4.46B--4.81B
Operating gains losses -----5,452.89%-21.1B--0---21.05B13.33%-39M95.24%-8M38.41%-380M-943.75%-167M--0---45M
Depreciation and amortization -3.46%1.82B7.40%7.49B4.01%1.84B8.55%1.83B10.89%1.93B6.27%1.88B-5.68%6.97B-3.85%1.77B-7.11%1.69B--1.74B
Deferred tax -1.23%-1.56B-152.19%-4.19B-392.36%-2.41B502.88%560M43.85%-799M-66.63%-1.54B20.01%-1.66B70.10%825M92.60%-139M---1.42B
Other non cash items ------483M--------------------------------
Change In working capital -114.94%-338M162.50%2.51B362.07%3.25B-1,906.67%-602M-79,933.33%-2.4B182.62%2.26B5.36%-4.01B20.98%-1.24B-100.86%-30M---3M
-Change in receivables -416.67%-279M51.63%-624M-24.58%227M-22.93%-252M43.17%-545M87.35%-54M46.29%-1.29B151.54%301M18.65%-205M---959M
-Change in inventory 33.59%-348M47.65%-1.32B119.08%124M-13.87%-706M66.97%-217M12.67%-524M-102.48%-2.53B-828.57%-650M-72.22%-620M---657M
-Change in payables and accrued expense 3.46%-2.48B113.66%2.35B75.76%1.68B31.58%1.73B-8.26%1.51B8.70%-2.57B-54.94%1.1B-57.56%957M-69.02%1.31B--1.65B
-Change in other current assets 449.62%3.2B-606.55%-3.48B45.46%-2.11B-121.43%-222M-109.04%-229M-191.96%-915M134.98%687M4.20%-3.88B55.32%1.04B--2.53B
-Change in other current liabilities -106.75%-427M382.36%5.59B64.02%3.33B26.10%-1.15B-13.83%-2.92B5,652.73%6.33B-86.52%-1.98B131.36%2.03B-96.95%-1.55B---2.57B
Cash from discontinued investing activities
Operating cash flow 12.28%3.66B7.54%22.79B46.97%7.86B19.18%7.49B-25.07%4.18B-18.15%3.26B-9.47%21.19B-6.66%5.35B-24.20%6.28B--5.58B
Investing cash flow
Cash flow from continuing investing activities -114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B37.44%-1.7B-2.64B
Net PPE purchase and sale 6.49%-807M-13.32%-4.54B-0.13%-1.59B-1.58%-967M-30.24%-1.12B-42.17%-863M-9.78%-4.01B-12.16%-1.59B-27.44%-952M---863M
Net intangibles purchase and sale -------470M------------------0------------
Net business purchase and sale ---1.81B--0--0--0--0--0-29,320.00%-17.65B-28,450.00%-17.13B--1M---271M
Net investment purchase and sale -91.26%349M-8.03%8.48B-80.96%2.68B1,163.86%4.42B-52.19%-2.6B247.03%3.99B271.21%9.23B519.32%14.06B84.42%-415M---1.71B
Net other investing changes 870.43%1.81B-4,089.23%-2.59B-811.33%-1.82B-170.75%-907M-125.00%-51M410.00%186M-84.41%65M148.21%256M-148.41%-335M--204M
Cash from discontinued investing activities
Investing cash flow -114.00%-464M107.10%878M72.66%-1.2B249.38%2.54B-43.08%-3.78B191.22%3.32B-42.47%-12.37B17.97%-4.4B37.44%-1.7B---2.64B
Financing cash flow
Cash flow from continuing financing activities -91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B-77.84%-3.93B-2.26B
Net issuance payments of debt -66.04%4.37B-136.69%-2.73B-115.03%-1.1B-6,336.13%-7.42B-78,955.56%-7.1B41,448.39%12.88B852.73%7.45B243,200.00%7.29B-81.80%119M--9M
Net common stock issuance 58.30%-1.48B86.53%-813M83.64%-216M57.51%-920M496.71%3.86B-124.29%-3.54B-74.62%-6.04B-32.53%-1.32B-453.71%-2.17B---973M
Cash dividends paid 2.48%-2.87B-0.75%-11.77B3.01%-2.87B3.33%-2.87B-4.07%-3.09B-5.56%-2.94B-5.89%-11.68B-5.84%-2.95B-6.41%-2.97B---2.97B
Proceeds from stock option exercised by employees 1,872.73%195M-17.68%1.09B-55.69%187M650.57%653M-46.89%265M-103.43%-11M28.28%1.33B85.09%422M-67.17%87M--499M
Net other financing activities 227.38%321M-2,564.62%-1.6B61.80%-665M-175.50%-758M-93.79%73M32.44%-252M-83.54%65M-1,481.75%-1.74B1,692.86%1B--1.18B
Cash from discontinued financing activities
Financing cash flow -91.10%546M-78.39%-15.83B-373.82%-4.66B-188.33%-11.32B-164.97%-5.99B239.98%6.14B36.85%-8.87B149.48%1.7B-77.84%-3.93B---2.26B
Net cash flow
Beginning cash position 54.73%21.86B-2.48%14.13B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B3.59%14.49B-35.50%11.36B-23.37%10.98B--10.46B
Current changes in cash -70.58%3.74B16,441.67%7.84B-24.39%2.01B-295.59%-1.29B-920.12%-5.59B414.60%12.71B-107.06%-48M186.59%2.65B-80.44%658M--681M
Effect of exchange rate changes -546.43%-125M64.10%-112M5.04%125M41.26%-168M39.75%-97M75.00%28M-75.28%-312M324.53%119M-210.87%-286M---161M
End cash Position -5.18%25.47B54.73%21.86B54.73%21.86B73.74%19.73B92.87%21.18B156.76%26.87B-2.48%14.13B-2.48%14.13B-35.50%11.36B--10.98B
Free cash flow 19.05%2.85B3.45%17.78B54.24%5.8B22.32%6.52B-35.18%3.06B-29.00%2.39B-13.02%17.19B-12.83%3.76B-29.31%5.33B--4.72B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.07%